New packaging solutions for life sciences, all at PACK EXPO in Chicago
Discover new packaging solutions from hundreds of suppliers specializing in life sciences, all under one roof at PACK EXPO International in Chicago.

FDA committee recommends Sandoz biosimilar for approval

If approved by the agency, Sandoz will market the biosimilar under the name ZARXIO.

The U.S. is inching closer to approving its first biosimilar.

The FDA's Oncologic Drugs Advisory Committee unanimously recommended the approval of Sandoz' biosimilar that is comparable to Amgen's Neupogen.

"We are pleased with the ODAC's recommendation to approve our biosimilar filgrastim and we look forward to continuing to work with FDA as it completes its review of our filing," said Mark McCamish, M.D., Ph.D., Head of Global Biopharmaceutical & Oncology Injectables Development at Sandoz, in a news release.

The decision came after recent documents from FDA reviewers decided that there are "no clinically meaningful difference" between Amgen's Neupogen, and Sandoz's biosimilar version.

If approved in the U.S., Sandoz proposes to market the biosimilar under the name ZARXIO.

The drug is used during chemotherapy to fight off infections.

Sandoz is a Novartis company. 

Explore new technology from hundreds of life sciences suppliers.
At PACK EXPO International, you’ll find innovations from hundreds of exhibitors that specialize in pharmaceuticals, biologics, nutraceuticals, medical devices and more. No other show delivers as many solutions to keep your products safe and effective.
Read More
Explore new technology from hundreds of life sciences suppliers.
New food packaging & processing solutions, all at PACK EXPO in Chicago
Experience the cutting edge of food packaging and processing innovation at PACK EXPO International this November. See machinery and equipment in action, discover new technologies, and learn sustainable solutions from experts, all in one place.
Read More
New food packaging & processing solutions, all at PACK EXPO in Chicago